1.97
Biote Corp stock is traded at $1.97, with a volume of 297.91K.
It is up +5.91% in the last 24 hours and up +40.71% over the past month.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
See More
Previous Close:
$1.86
Open:
$1.87
24h Volume:
297.91K
Relative Volume:
1.26
Market Cap:
$63.13M
Revenue:
$192.22M
Net Income/Loss:
$31.60M
P/E Ratio:
2.5993
EPS:
0.7579
Net Cash Flow:
$28.33M
1W Performance:
+34.01%
1M Performance:
+40.71%
6M Performance:
-31.83%
1Y Performance:
-42.90%
Biote Corp Stock (BTMD) Company Profile
Name
Biote Corp
Sector
Industry
Phone
972-486-9346
Address
1875 W. WALNUT HILL LN #100, IRVING
Compare BTMD vs MOBBW, GOODO, PSNYW, SHMD, DWLD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
BTMD
Biote Corp. Class A Common Stock
|
5.89 | 33.33M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
1.82 | 2.55B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
19.85 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
3.70 | 356.14M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
SHMD
Schmid Group N V
|
5.81 | 315.27M | 52.15M | -21.46M | 0 | -0.4675 |
|
DWLD
Davis Select Worldwide ETF
|
46.21 | 0 | 0 | 0 | 0 | 0.00 |
Biote Corp Stock (BTMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-25 | Downgrade | B. Riley Securities | Buy → Neutral |
| Dec-16-24 | Initiated | Craig Hallum | Buy |
| Feb-20-24 | Initiated | B. Riley Securities | Buy |
| Feb-01-24 | Initiated | Jefferies | Buy |
| Jun-24-22 | Initiated | Cowen | Outperform |
| Jun-23-22 | Initiated | ROTH Capital | Buy |
View All
Biote Corp Stock (BTMD) Latest News
Growth Value: Why is biote Corp stock going upCEO Change & Technical Entry and Exit Alerts - baoquankhu1.vn
Layoff Watch: Is biote Corp gaining market share2026 Fundamental Recap & Community Verified Trade Alerts - baoquankhu1.vn
Sentiment Recap: Why is biote Corp stock going upTrend Reversal & Technical Pattern Alert System - baoquankhu1.vn
BTMD Technical Analysis & Stock Price Forecast - Intellectia AI
Biote Corp. 2025-2026 Outlook: Leading Hormone Optimization and Therapeutic Wellness Market Expansion 345 - Minichart
How The Investment Story For Biote (BTMD) Is Shifting With Reset Expectations And 2026 Guidance - Yahoo Finance
Biote Updates April 2026 Investor Presentation on Growth - TipRanks
Biote posts April 2026 investor presentation highlighting $192.2M 2025 revenue and $53.5M Adj. EBITDA - TradingView — Track All Markets
Biote (NASDAQ: BTMD) highlights 2025 revenue and 2026 guidance - Stock Titan
biote Corp. (BTMD) CEO awarded 441,653 stock options at $1.43 strike price - Stock Titan
biote Corp. (BTMD) CFO receives 107,169 employee stock options at $1.43 - Stock Titan
biote (NASDAQ:BTMD) Stock Price Up 11.2%What's Next? - MarketBeat
Biote (BTMD) details 2026 virtual meeting, board elections and pay - Stock Titan
[ARS] biote Corp. SEC Filing - Stock Titan
Downgrade Watch: Why is biote Corp stock going upWeekly Profit Recap & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Fed Meeting: Is biote Corp gaining market share2026 Key Highlights & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
Risk Hedge: Is biote Corp stock overvalued or fairly pricedRecession Risk & Target Return Focused Stock Picks - baoquankhu1.vn
Biote Corp. (BTMD) Q1 Earnings and Revenues Surpass Estimates - MSN
Tranche Update on biote Corp.'s Equity Buyback Plan announced on January 25, 2024. - marketscreener.com
Macro Review: Does biote Corp align with a passive investing strategyMarket Activity Recap & Capital Efficient Trading Techniques - baoquankhu1.vn
biote Corp. Stock Plummets to New 52-Week Low of $1.68 - Markets Mojo
biote Corp. Hits 52-Week Low of $1.73 Amid 72.2% Decline - Markets Mojo
biote Corp. Hits New 52-Week Low at $1.86 Amidst Major Decline - Markets Mojo
Whale Trades: What hedge funds are buying biote CorpWeekly Trend Report & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Setup Watch: Is biote Corp gaining market share2026 Trends & AI Driven Stock Reports - baoquankhu1.vn
Does biote Corp have declining or rising EPS2026 Momentum Check & Community Trade Idea Sharing Platform - baoquankhu1.vn
Can biote Corp stock outperform in a bear market2026 Fundamental Recap & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Inventory Forecasting Woes: Biote Corp. Faces Material Risk From Demand Volatility and Stock Management Challenges - The Globe and Mail
Biote 2025 Annual Report: Hormone Optimization Practice Growth, Risk Factors, and Business Overview - Minichart
Biote Corp. Q4 2025 Earnings Call Insights - Intellectia AI
Cowen Maintains Buy on biote Corp. (BTMD) March 2026, PT $2.50 - Meyka
Tranche Update on biote Corp.'s Equity Buyback Plan announced on June 20, 2024. - marketscreener.com
Biote Corp. Earnings Call Maps Pain Now, Promise Later - TipRanks
Biote : Fourth Quarter 2025 Earnings Call Transcript - marketscreener.com
Roth/MKM cuts Biote stock price target on procedure uncertainty By Investing.com - Investing.com India
B. Riley Financial Cuts biote (NASDAQ:BTMD) Price Target to $2.00 - MarketBeat
TD Cowen cuts Biote stock price target on guidance miss By Investing.com - Investing.com Canada
TD Cowen cuts Biote stock price target on guidance miss - Investing.com
Roth/MKM cuts Biote stock price target on procedure uncertainty - Investing.com
Biote Corp (BTMD) Q4 EPS Plunges 84% to $0.06 Despite Flat Revenue at $49.5M - AlphaStreet
biote Corp earnings missed by $0.03, revenue fell short of estimates - Investing.com Australia
biote Corp. (NASDAQ:BTMD) Q4 2025 Earnings Call Transcript - Insider Monkey
B. Riley Adjusts Price Target on biote to $2 From $3, Maintains Neutral Rating - marketscreener.com
Biote Corp (BTMD) Q4 2025 Earnings Call Highlights: Strategic Growth Amid Revenue Challenges By GuruFocus - Investing.com Canada
biote Corp. Q4 2025 Earnings Call Summary - Yahoo Finance
biote Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: Biote Corp misses Q4 2025 earnings expectations By Investing.com - Investing.com India
Earnings call transcript: Biote Corp misses Q4 2025 earnings expectations - Investing.com
BTMD: Q4 revenue fell on clinic attrition and recall, but sales and tech investments target H2 2026 growth - TradingView
biote Corp. (BTMD) Q4 Results Surpass Expectations for Earnings and Revenue - Bitget
Biote Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Biote Corp Stock (BTMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Biote Corp Stock (BTMD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Guines LLC | 10% Owner |
May 07 '25 |
Buy |
3.35 |
11,677 |
39,107 |
4,622,748 |
| Guines LLC | 10% Owner |
Apr 30 '25 |
Buy |
3.30 |
1,933 |
6,371 |
4,175,034 |
| Guines LLC | 10% Owner |
Apr 21 '25 |
Buy |
3.27 |
8,801 |
28,782 |
4,173,101 |
| Guines LLC | 10% Owner |
Apr 17 '25 |
Buy |
3.29 |
6,874 |
22,615 |
4,164,300 |
| Guines LLC | 10% Owner |
Apr 16 '25 |
Buy |
3.29 |
1,000 |
3,292 |
4,157,426 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):